U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898905) titled 'Hyperfractionated Dual Equivalent Fractionated Radiation Therapy' on March 18. Brief Summ... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898697) titled 'Midazolam or Fentanyl as Adjuvants to Epidural Bupivacaine Plus Dexamethasone for Analgesi... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898671) titled 'Language Outcomes, Mechanisms, and Trajectories in Adults With and Without Developmental L... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898177) titled 'Development and Testing of a Mobile App to Scale Delivery of Cognitive-behavioral Therapy ... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06899347) titled 'The Role of Prophylactic Central Compartment Neck Dissection in the Management of 2 to 4 C... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898047) titled 'Consistency of Response With Rimegepant in Acute Treatment of Migraine' on March 20. Brie... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898398) titled 'TACE Combined Surgery for the Resectable Huge HCC' on March 21. Brief Summary: Huge hepat... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898645) titled 'Efficacy of Cerebellar Transcranial Magnetic Stimulation to Treat Hereditary Spinocerebell... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898593) titled 'Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients' on March 1... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898853) titled 'The Effect of 0.1% Topical Ciclosporin a for 12-weeks on the Eye Surface Immune Cells in D... Read More